BioSpectrumIndia - the business of biotech

HOME

SITEMAP

FEEDBACK

ARCHIVES

MEDIA KIT

Search:

Help

Home > Pharma

Pharma
"The next generation products will be oral insulin"

"We intend to be a leader in the Asia Pacific region"

"We have plenty of opportunities to in-license latest drugs and work on them,"

Anticancer focus on the rise

"We intend to be a leader in the Asia Pacific region"

Jubilant Organosys Q1 net up three-fold

Pharma Round-up

Bio Pharma

First gene-based asthma drug almost ready

Millions of people prone to asthmatic attacks can look forward to throwing away their steroid inhalers and ward it off with injections of Xolair, the world’s first drug developed through the genetic engineering technologies against this disorder. In mid-May, a panel of experts at the US government’s Food and Drug Administration (FDA) has recommended its use among patients from ages 12 to 65 suffering from moderate to severe form of allergic attacks.

Opportunities unfurling

Medical biotechnology has gained prominence in the country with spectacular advances in biology. This is mainly due to a number of emerging and re-emerging infections requiring immediate attention for development of suitable diagnostics and therapeutics. Now biopharma has become an important component of the national economy.

Current Issue

Read Testimonials

EDITORIAL

The right time for biotechnology

BIONEWS

	Biocon, Amylin to jointly develop diabetes drug
more »

EVENTS

	Jury picks BioSpectrum 2009 awardees
more »

About BioSpectrum | Feedback | Contact Us | jobs@Cybermedia

Copyright © CyberMedia All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.
Usage of this web site is subject to terms and conditions.

Broken links? Problem with site? Send email to webmaster@cybermedia.co.in